Back

Therapeutic role of Prostaglandin E2 receptor 4 stimulation in inflammatory cardiomyopathy

27 August 2021 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Novel therapies for heart failure in the early pipeline Pharmacotherapy ESC Premium Access ESC Congress 2021 - The Digital Experience

About the speaker

Photo
Doctor Takakuma Akira

Yokohama City University Hospital, Yokohama (Japan)

2 More presentations in this session

Presentation thumbnail
Low level transcutaneous vagus nerve stimulation reverses cardiac dysfunction and changes left ventricular gene expression in a rat model of heart failure with preserved ejection fraction
Doctor M. Niewiadomska (Oklahoma City, US)
Abstract Slides Video
Presentation thumbnail
Empagliflozin improves prognosis and energetic properties through modulating mitochondrial function in failing murine hearts
Professor A. Shiraki (Saga, JP)
Abstract Slides Video

Access the full session

Session thumbnail
Novel therapies for heart failure in the early pipeline

The Event

Event poster

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021
You may be interested in
thumbnail
Congress Presentation
Breaking the barriers in guideline-directed medical therapy implementation in heart failure - discussion
thumbnail
Congress Presentation
The role of ICD therapy in heart failure in 2024. What is the holistic approach to treat heart failure?
thumbnail
Congress Session
Guideline-directed medical therapy implementation in special clinical scenarios

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources